All In MedTech

510(k) device

Medtronic Minimed Paradigm Insulin Pumps

Medtronic Minimed · Pump, Infusion, Insulin (LZG, Class II) · First FDA decision May 21, 2004, newest Mar 29, 2012Diabetes

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Medtronic Minimed Paradigm Insulin Pumps

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology, with pictures of the device
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 4 of 4 decisions filed under this name.

3 more FDA decisions with a free account

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "Minimed Paradigm", any status and sponsor, newest update first.

Open in Trial Radar

21 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Minimed Paradigm", and for the whole product code for context.

Newest reports for this brand

4 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Medtronic MiniMed, Inc.

    Z-1748-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026

    Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...

    Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin (LZG)

8 more recall records with a free account

Published research

The most relevant PubMed records for "Minimed Paradigm"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code LZG.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.